• 제목/요약/키워드: metabolic changes

검색결과 817건 처리시간 0.039초

콩 단백질 섭취 및 트레드밀 운동이 난소절제 흰쥐의 신체구성, 혈중 대사변인, 에스트라디올 농도 및 에스트로겐 수용체 유전자 발현에 미치는 영향 (Effects of soy protein supplementation and treadmill running exercise on the changes of body composition, blood metabolic markers, estradiol, estrogen receptor gene expression in ovariectomized rats)

  • 김기진
    • 운동과학
    • /
    • 제21권2호
    • /
    • pp.243-254
    • /
    • 2012
  • 본 연구는 폐경에 따른 에스트로겐 대사의 부정적인 영향의 방지 및 처치를 위한 효율적인 대체요법으로서 운동과 콩 단백질 추출물 섭취 프로그램의 활용가능성을 제시하고자 한다. 이에 난소 절제하여 폐경과 동일한 상태를 유도한 흰쥐를 대상으로 8주 동안 트레드밀을 이용한 지구성 운동과 콩 단백질 추출물 섭취의 복합적인 처치가 신체구성 및 골밀도, 혈중 에스트라디올농도, 간 조직에서의 에스트로겐 수용체의 유전자 발현양상, 혈중 글루코스, 중성지방, 인슐린 및 CRP 농도 등의 변화에 미치는 영향을 분석하였다. 난소절제그룹은 체중 및 체지방률이 증가하고, 혈중 에스트라디올농도 및 간 조직에서의 에스트로겐 수용체의 유전자 발현이 감소하였으며, 혈중 중성지방농도는 증가하였다. 8주간의 운동 및 콩 단백질 섭취에 의한 처치 후 에스트라디올농도, 에스트로겐 수용체 및 혈중 변인 등에 긍정적인 효과를 나타냈으나 골밀도에는 영향을 미치지 못한 것으로 나타났다. 따라서 난소절제 흰쥐의 8주간 운동 및 콩 단백질 추출물 처치가 에스트로겐 및 지방대사에 긍정적인 영향을 미칠 수 있는 가능성은 확인 되었으나, 운동강도 및 시간, 콩 단백질의 섭취량을 포함한 처치기간 등에 대한 계속적인 검토가 요구된다고 생각된다.

The Combination of Bacillus natto JLCC513 and Ginseng Soluble Dietary Fiber Attenuates Ulcerative Colitis by Modulating the LPS/TLR4/NF-κB Pathway and Gut Microbiota

  • Mingyue Ma;Yueqiao Li;Yuguang He;Da Li;Honghong Niu;Mubai Sun;Xinyu Miao;Ying Su;Hua Zhang;Mei Hua;Jinghui Wang
    • Journal of Microbiology and Biotechnology
    • /
    • 제34권6호
    • /
    • pp.1287-1298
    • /
    • 2024
  • Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that is currently difficult to treat effectively. Both Bacillus natto (BN) and ginseng-soluble dietary fiber (GSDF) are anti-inflammatory and helps sustain the intestinal barrier. In this study, the protective effects and mechanism of the combination of B. natto JLCC513 and ginseng-soluble dietary fiber (BG) in DSS-induced UC mice were investigated. Intervention with BG worked better than taking BN or GSDF separately, as evidenced by improved disease activity index, colon length, and colon injury and significantly reduced the levels of oxidative and inflammatory factors (LPS, ILs, and TNF-α) in UC mice. Further mechanistic study revealed that BG protected the intestinal barrier integrity by maintaining the tight junction proteins (Occludin and Claudin1) and inhibited the LPS/TLR4/NF-κB pathway in UC mice. In addition, BG increased the abundance of beneficial bacteria such as Bacteroides and Turicibacter and reduced the abundance of harmful bacteria such as Allobaculum in the gut microbiota of UC mice. BG also significantly upregulated genes related to linoleic acid metabolism in the gut microbiota. These BG-induced changes in the gut microbiota of mice with UC were significantly correlated with changes in pathological indices. In conclusion, this study demonstrated that BG exerts protective effect against UC by regulating the LPS/TLR4/NF-κB pathway and the structure and metabolic function of gut microbiota. Thus, BG can be potentially used in intestinal health foods to treat UC.

Shalf Life Enhancement of Minimally Processed Fruits and Vegetables

  • Kim, Dong-Man
    • 한국식품저장유통학회:학술대회논문집
    • /
    • 한국식품저장유통학회 1993년도 정기총회 및 제3차 학술발표회
    • /
    • pp.6-9
    • /
    • 1993
  • According to changes in population, economic conditions, life-stile and eating habits, the frui ts and vegetables market wi 11 be shi fted from processed (i. e. , canned) to fresh. Undressed fresh produce, consisting of washed, disinfected and peeled fruits and vegetables that either sliced or grated, are currently increased in demand by retail and institutional market which use them as salad components or in ready-to use foods, Main attributes of minimally processed fruits and vegetables are convenience and fresh-like quality. Minimally processed Products readily deteriorate in quality, especially color and texture, as a result of endogeneous enzyme enhanced respiration and microorganisms which lead to reduced shelf Iife. According to changes in population, economic conditions, life-stile and eating habits, the frui ts and vegetables market wi 11 be shi fted from processed (i. e. , canned) to fresh. Undressed fresh produce, consisting of washed, disinfected and peeled fruits and vegetables that either sliced or grated, are currently increased in demand by retail and institutional market which use them as salad components or in ready-to use foods, Main attributes of minimally processed fruits and vegetables are convenience and fresh-like quality. Minimally processed Products readily deteriorate in quality, especially color and texture, as a result of endogeneous enzyme enhanced respiration and microorganisms which lead to reduced shelf Iife. Thus. to prevent these undesirable changes , val'ious techniques such as controlled atmosphere (CA) storage, modified atmosphere OIA) storage, including vacuum packaging have been receiving considerable attention, Although milch research has been done to find optimal conditions for whole intact frui ts and vegetables, only limi ted information is avai lable on fresh cut. and other minimally processed products. 81 iced frui ts exhibi t increas~d ethylene production and respiration compal'ed to whole f, 'uits during distribution in response to tissue damage. As a result, accelerated senescence and enzymatic browning OCCUI', Recent l'esearch on minimally processed fl'uits and vegetables has mainly focused on methods to inhibit browning, due to ban on use of sulfur dioxide, In order to retard or prevent these physiological changes, val'ious al ternatives, reducing agents. acidulants, chelating agents and inol'ganic sal ts have been evaluated for use on fresh cut fl'ui ts. Al though some agents were effective replacement for sulfur dioxide. consum$\textregistered$I'S demandless use of chemical on such products. Shel~ life of minimally processed products has been extended by inhibition of metabolic reactions associated with loss of quality and by inhibition of aerobic spoilage caused by wide variety of microorganisms. Appl ication of ~I.-\ packaging, including vacuum packaging, retards the rate of respiration, prevents growth of aerobic spoilage organisms, inhibits oxidation and color deterioration. Tissue softening is another major problem in minimally processed products because enzymes re 1 a ted to ce 11 wa 11 degrada t i on are not inactivated. Various treatments have been investigated for retardation of the softening of sliced products. Some studies have concentrated on the application of an active packaging system with ~I, l. packaging and calcium infi 1 tration as possible measures to retain firmness of processed products. In my opinion, one important step for production of minimally processed frui ts wi th favorabl e color of cut surface and firm texture is the selection of better cultivar. As the view, changing tendency of fresh color by apple cultivars and relationship between the tendency and PPO activity will be discussed in the seminar. In addition to the topic, research result on quality enhancement of fresh apple slices by heat shock treatment will be introduced.

  • PDF

Variability in Drug Interaction According to Genetic Polymorphisms in Drug Metabolizing Enzymes

  • Jang, In-Jin;Yu, Kyung-Sang;Cho, Joo-Youn;Chung, Jae-Yong;Kim, Jung-Ryul;Lim, Hyeong-Seok;Shin, Sang-Goo
    • 한국환경성돌연변이발암원학회지
    • /
    • 제24권1호
    • /
    • pp.15-18
    • /
    • 2004
  • There are significant differences in the extent of drug interactions between subjects. The influence of the genetic make up of drug metabolizing enzyme activities (CYP3A5, CYP2C19 and UDP-glucuronosyl transferase) on the pharmacokinetic drug interaction potential were studied in vivo. Nineteen healthy volunteers were grouped with regard to the $CYP3A5^{*}3$ allele, into homozygous wild-type (CYP3A5^{*}1/1^{*}1$, n=6), heterozygous $(CYP3A5^{*}1/^{*}3$, n=6), and homozygous variant-type $(CYP3A5^{*}3/^{*}3$, n=7) subject groups. The pharmacokinetic profile of intravenous midazolam was characterized before and after itraconazole administration (200 mg once daily for 4 days), and also following rifampin pretreatment (600 mg once daily for 10 days), with a washout period of 2 weeks in between. For omeprazole and moclobemide pharmacokinetic interaction study 16 healthy volunteers were recruited. The volunteer group comprised 8 extensive metabolizers and 8 poor metabolizers of CYP2C19, which was confirmed by genotyping. Subjects were randomly allocated into two sequence groups, and a single-blind, placebo-controlled, two-period crossover study was performed. In study I, a placebo was orally administered for 7 days. On the eighth morning, 300 mg of moclobemide and 40 mg of placebo were coadministered with 200 mL of water, and a pharmacokinetic study was performed. During study n, 40 mg of omeprazole was given each morning instead of placebo, and pharmacokinetic studies were performed on the first and eighth day with 300 mg of moclobemide coadministration. In the UGT study pharmacokinetics and dynamics of 2 mg intravenous lorazepam were evaluated before and after rifampin pretreatment (600 mg once daily for 10 days), with a washout period of 2 weeks in between. The subjective and objective pharmacodynamic tests were done before and 1, 2, 4, 6, 8, and 12 hrs after lorazepam administration. The pharmacokinetic profiles of midazolam and of its hydroxy metabolites did not show differences between the genotype groups under basal and induced metabolic conditions. However, during the inhibited metabolic state, the $CYP3A5^{*}3/^{*}3$ group showed a greater decrease in systemic clearance than the $CYP3A5^{*}1/^{*}1$ group $(8.5\pm3.8$ L/h/70 kg vs. $13.5\pm2.7$ L/h/70 kg, P=0.027). The 1'-hydroxymidazolam to midazolam AUC ratio was also significantly lower in the $CYP3A5^{*}3/^{*}3$,/TEX> group $(0.58\pm0.35,$ vs. $1.09\pm0.37$ for the homozygous wild-type group, P=0.026). The inhibition of moclo-bemide metabolism was significant in extensive metabolizers even after a single dose of omeprazole. After daily administration of omeprazole for 1 week, the pharmacokinetic parameters of moclobemide and its metabolites in extensive metabolizers changed to values similar to those in poor metabolizers. In poor meta-bolizers, no remarkable changes in the pharmacokinetic parameters were observed. The area under the time-effect curves of visual analog scale(VAS), choice reaction time, and continuous line tracking test results of lorazepam was reduced by 20%, 7%, 23% respectively in induced state, and in spite of large interindividual variablity, significant statistical difference was shown in VAS(repeated measures ANOVA, p=0.0027).

  • PDF

DL-1-Aminoethylphosphonic acid의 생물학적(生物學的) 기능연구(機能硏究) (A Study of Synthesis and Biological Function on DL-1-Aminoethylphosphonic Acid)

  • 김숙희;조정남;김용준
    • Journal of Nutrition and Health
    • /
    • 제2권4호
    • /
    • pp.173-181
    • /
    • 1969
  • 생후 $40{\pm}5$ 일된 젖떨어진 Albino Rat female male 각각 30마리를 크게 Alanine(AL)과 Aminoethylphosphonic acid(AEP) group으로 나누고 각 group을 다시 각각 2 group으로 나누어 female male Alanine 0.1%, female male Alanine 0.2%와 female male AEP 0.1%, female male AEP 0.2% 합(合) 8 group으로 나누어 14 주동안 실험한 결과의 요약은 다음과 같다. 단백질 효율과 뇨중 질소배설량에 어떤 유의적인 차이가 없음으로 AEP도 다른 일반적인 Amino acid와 같은 정도로 체내에서 이용됨을 알 수 있다. AEP의 첨가로 인한 p의 이용율의 변화 유무를 판정하기 위하여 뇨중 p의 함량을 측정한 결과 모든 group사이에 유의성이 없었음으로 alanine 첨가 group에서나 AEP 첨가 group에서나 같은 정도로 체내에서 이용됨을 알 수있으나 AEP의 첨가로 인한 Dietary Phosphorus함량이 높음으로 인하여 체내 보유량이 많다는 것을 알 수 있으며 이는 blood phosphorus 함량측정을 해본 결과와 일치함을 알 수 있다. 간질소 함량을 측정하여 본 결과 AEP 첨가가 간질소 함량을 높일 수 있으며 0.2%쪽이 더 많은 양을 간에 보유할 수 있다는 것을 알았다. 간지방 함량도 간질소 함량과 같은 방향으로 나타났으며 조직 검사로 fat lumps를 발견할 수 없었으므로 AEP 첨가가 fatty liver의 요인이 될 수 없다는 것을 알 수 있다. Amino acid의 생물학적 가치와 Amino acid의 조성사이에는 현저한 관계가 있어 양적으로 충분한 단백질을 섭취한다 하더라도 섭취한 단백질이 함유하고 있는 Amino acid의 종류 및 각종 Amino acid의 비율에 따라서 소화에 현저한 차이가 있어 생물학적 기능이 다르다는 것이 Oser와 그외 여러 학자들에 의하여 보고되었다. 이 보고에 비추어 보아 0.2% diet에서 Amino acid의 장내 흡수시 imbalanced condition을 초래 한 것으로 본다.

  • PDF

제1형 당뇨병 소아 환자에서 동맥경화증의 조기 평가 (Early assessment of atherosclerosis in children with type 1 diabetes)

  • 박소윤;강석정;최광해;박용훈;이영환
    • Clinical and Experimental Pediatrics
    • /
    • 제51권7호
    • /
    • pp.747-753
    • /
    • 2008
  • 목 적 : 제1형 당뇨병은 동맥경화증의 주요 위험인자 중의 하나로 이러한 동맥경화증의 초기 변화가 소아청소년기부터 시작된다는 것은 잘 알려진 사실이다. 성인에서는 초음파를 이용한 경동맥 내중막 두께가 동맥경화증의 독립적인 대리 표식자로 널리 이용되고 있으나, 소아청소년기에 관한 연구는 흔하지 않다. 이에 저자들은 제1형 당뇨병을 가진 소아들을 대상으로 경동맥 내막-중막 두께 및 경동맥 혈관 탄성 지수 측정을 통해 혈관의 동맥경화 상태를 조기에 평가하고, 이러한 혈관의 변화와 여러 동맥경화 위험인자들과의 관련성을 파악하여 조기 동맥경화의 선별 검사로 경동맥 내막-중막 두께의 유용성 등에 대해 알아보고자 본 연구를 시행하였다. 방 법 : 대구지역 3차 병원 소아과에서 제1형 당뇨병으로 진단받고 치료 중인 환자 23명과 동일 연령 및 성별의 건강한 소아, 청소년 19명을 대상으로 신체계측을 하고 공복상태에서 혈청콜레스테롤 및 당화혈색소를 측정하였다. 또한 고해상도 초음파를 이용하여 심장 주기에 따른 우측 경동맥의 내경 및 내중막 두께를 측정하였으며 공식에 따라 경동맥 유순도 및 신전도를 구하였다. 결 과 : 두 군 간의 성별, 연령, 혈압과 혈청콜레스테롤 등은 차이가 없었다. 경동맥 초음파 소견에서 당뇨군의 경동맥 내막-중막 두께는 의미 있게 증가되었으나 유순도와 신전도의 차이는 없었다. 당화혈색소와 고밀도혈청콜레스테롤은 다른 동맥경화의 위험인자와 독립적으로 경동맥 내막-중막 두께에 영향을 미치는 것으로 나타났다. 결 론 : 제1형 소아 당뇨 환아의 경우 정상 환아에 비해 경동맥 내막-중막 두께가 의미 있게 증가되어 있고, 이것이 혈당 조절 정도나 혈청 지질치와 같은 심혈관계의 위험인자와 깊은 상관관계를 나타내는 것으로 보아 소아 당뇨 환아에서 동맥경화의 발생을 조기에 파악하는 선별 검사로서 경동맥 내막-증막 두께는 유용하다고 생각된다.

3T Multi Voxel Spectroscopy에서 SENSE와 NEX 변화에 따른 정상인 뇌 대사물질 변화 분석 (Alteration Analysis of Normal Human Brain Metabolites with Variation of SENSE and NEX in 3T Multi Voxel Spectroscopy)

  • 성열훈;임재동;이재현;조성봉;우동철;최보영
    • 한국의학물리학회지:의학물리
    • /
    • 제19권4호
    • /
    • pp.256-262
    • /
    • 2008
  • 자기공명분광법(magnetic resonance spectroscopy: MRS)은 인체내 대사물질을 정량분석하여 병변의 조기진단 및 정밀진단에 도움을 주고 있으며, 최근 임상에 이용되고 있는 자기공명분광법은 single voxel spectroscopy (SVS) 기법과 multi voxel spectroscopy (MVS) 기법이 있다. 본 연구에서는 SENSE와 NEX를 변화시킨 multi voxel spectroscopy (MVS)의 데이터와 기존 single voxel spectroscopy (SVS)의 데이터를 비교 분석하여, 각각의 데이터의 유의성 차이를 평가하고자 하였다. 정상 성인 지원자 13명(남자: 5명, 여자: 8명, 평균 41세, 표준편차 11.65세)을 대상으로 chemical shift image (CSI)를 이용한 MVS검사를 시행하였다. 장비는 3.0T Achieva Release Version 2.1 (Philips Medical System, Netherland)을 이용하였고, 8 channel head coil을 사용하여 brain thalamus 부위에서 CSI spectrum을 1 slice 획득하였다. Scan parameter로는 FOV (field of view): $230{\times}184mm^2$, TR (time to repetition): 2000 msec, TE (time to echo): 288 msec, matrix: $15{\times}12$, VOI(view of interest): $110{\times}110mm^2$, voxel size: $15{\times}15{\times}15mm^3$로 하였다. SENSE factor (S)와 NEX (N)는 S1*N1, S2*N1, S2*N2, S3*N2로 변화하여 스펙트럼을 획득하였고, 각 scan time은 5분 54초, 3분 32초, 6분 20초, 4분 20초였다. 얻은 모든 MRS 데이터는 jMRUI 3.0 Version 프로그램에서 분석하였고, SENSE factor와 NEX를 변화시켜 얻은 MVS data 그룹들이 정상 성인 뇌 대사물질의 변화에 영향을 주는지 검증하기 위해 그룹 간에 ANOVA분석을 실행하여 P 값이 0.05보다 크게 나오면 그룹들 사이에 유의한 차이가 없다고 분석하였다. NAA/Cr과 Cho/Cr의 상대적 비율은 MV와 SVS사이에서는 유의한 차이가 없었다. 즉, SENSE factor와 NEX를 변화시켜 얻은 MVS data에서 정상 성인 뇌조직의 대사물질의 변화를 관찰한 결과, S1*N1의 NAA/Cr은 $1.45{\pm}0.03$, Cho/Cr은 $0.88{\pm}0.03$이고, S2*N1의 NAA/Cr은 $1.44{\pm}0.03$, Cho/Cr은 $0.87{\pm}0.05$, S2*N2의 NAA/Cr은 $1.43{\pm}0.02$, Cho/Cr은 $0.87{\pm}0.04$이며, S3*N2의 NAA/Cr은 $1.45{\pm}0.03$, Cho/Cr은 $0.87{\pm}0.03$으로 나타났다(F-value : 1.37, D.F : 3, P-value : 0.262). 그러나 데이터의 질을 측정하기 위한 MVS 데이터의 NAA Peak line-width는 SVS 데이터의 NAA Peak line-width 보다 약 3배 정도 넓었다. 본 연구에서는 MVS에서 SENSE factor와 NEX 값을 다양하게 변화시킨 MVS의 데이터와 SVS의 데이터가 큰 차이가 없음을 확인하였다. 즉, 어는 특정 부위의 뇌 조직의 대사물질은 MVS와 SVS 기법 모두 큰 차이가 없음을 확인할 수 있었다. 그러므로 MVS는 SVS보다 광범한 부위를 짧은 시간 안에 검사할 수 있으므로 매우 유용한 방법이라고 사료된다.

  • PDF

Effects of ambient temperature and dietary glycerol addition on growth performance, blood parameters and immune cell populations of Korean cattle steers

  • Kang, Hyeok Joong;Piao, Min Yu;Lee, In Kyu;Kim, Hyun Jin;Gu, Min Jeong;Yun, Cheol-Heui;Seo, Jagyeom;Baik, Myunggi
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제30권4호
    • /
    • pp.505-513
    • /
    • 2017
  • Objective: This study was performed to evaluate whether ambient temperature and dietary glycerol addition affect growth performance, and blood metabolic and immunological parameters, in beef cattle. Methods: Twenty Korean cattle steers ($405.1{\pm}7.11kg$ of body weight [BW], $14.2{\pm}0.15$ months of age) were divided into a conventional control diet group (n = 10) and a 2% glycerol- added group (n = 10). Steers were fed 1.6% BW of a concentrate diet and 0.75% BW of a timothy hay diet for 8 weeks (4 weeks from July 28th to August 26th and 4 weeks from August 27th to September 26th). Blood was collected four times on July 28th, August 11th, August 27th, and September 26th. Results: The maximum indoor ambient temperature-humidity index in August (75.8) was higher (p<0.001) than that in September (70.0), and in August was within the mild heat stress (HS) category range previously reported for dairy cattle. The average daily gain (ADG; p = 0.03) and feed efficiency (p<0.001) were higher in hotter August than in September. Glycerol addition did not affect ADG and feed efficiency. Neither month nor glycerol addition affected blood concentrations of cortisol, triglyceride, or non-esterified fatty acid. Blood concentrations of cholesterol, low-density lipoprotein, high-density lipoprotein, glucose, and albumin were lower (p<0.05) on August 27th than on September 26 th, and blood phosphorus, calcium and magnesium concentrations were also lower on August 27th than on September 27th. Glycerol addition did not affect these blood parameters. Percentages of $CD4^+$ T cells and $CD8^+$ T cells were higher (p<0.05) on July 28th than on August 27th and September 26th. The blood $CD8^+$ T cell population was lower in the glycerol supplemented-group compared to the control group on July 28th and August 27th. Conclusion: Korean cattle may not be significantly affected by mild HS, considering that growth performance of cattle was better in hotter conditions, although some changes in blood metabolic and mineral parameters were observed.

Variability in Drug Interaction According to Genetic Polymorph isms in Drug Metabolizing Enzymes

  • Jang, In-Jin;Yu, Kyung-Sang;Cho, Joo-Youn;Chung, Jae-Yong;Kim, Jung-Ryul;Lim, Hyeong-Seok;Shin, Sang-Goo
    • 한국환경성돌연변이발암원학회지
    • /
    • 제23권4호
    • /
    • pp.131-134
    • /
    • 2003
  • There are significant differences in the extent of drug interactions between subjects. The influence of the genetic make up of drug metabolizing enzyme activities (CYP3A5, CYP2C19 and UDP-glucuronosyl transferase) on the pharmacokinetic drug interaction potential were studied in vivo. Nineteen healthy volunteers were grouped with regard to the $CYP3A5^{*}3$ allele, into homozygous wild-type (CYP3A5^{*}1/1^{*}1$, n=6), heterozygous $(CYP3A5^{*}1/^{*}3$, n=6), and homozygous variant-type $(CYP3A5^{*}3/^{*}3$, n=7) subject groups. The pharmacokinetic profile of intravenous midazolam was characterized before and after itraconazole administration (200 mg once daily for 4 days), and also following rifampin pretreatment (600 mg once daily for 10 days), with a washout period of 2 weeks in between. For omeprazole and moclobemide pharmacokinetic interaction study 16 healthy volunteers were recruited. The volunteer group comprised 8 extensive metabolizers and 8 poor metabolizers of CYP2C19, which was confirmed by genotyping. Subjects were randomly allocated into two sequence groups, and a single-blind, placebo-controlled, two-period crossover study was performed. In study I, a placebo was orally administered for 7 days. On the eighth morning, 300 mg of moclobemide and 40 mg of placebo were coadministered with 200 mL of water, and a pharmacokinetic study was performed. During study n, 40 mg of omeprazole was given each morning instead of placebo, and pharmacokinetic studies were performed on the first and eighth day with 300 mg of moclobemide coadministration. In the UGT study pharmacokinetics and dynamics of 2 mg intravenous lorazepam were evaluated before and after rifampin pretreatment (600 mg once daily for 10 days), with a washout period of 2 weeks in between. The subjective and objective pharmacodynamic tests were done before and 1, 2, 4, 6, 8, and 12 hrs after lorazepam administration. The pharmacokinetic profiles of midazolam and of its hydroxy metabolites did not show differences between the genotype groups under basal and induced metabolic conditions. However, during the inhibited metabolic state, the $CYP3A5^{*}3/^{*}3$ group showed a greater decrease in systemic clearance than the $CYP3A5^{*}1/^{*}1$ group $(8.5\pm3.8$ L/h/70 kg vs. $13.5\pm2.7$ L/h/70 kg, P=0.027). The 1'-hydroxymidazolam to midazolam AUC ratio was also significantly lower in the $CYP3A5^{*}3/^{*}3$,/TEX> group $(0.58\pm0.35,$ vs. $1.09\pm0.37$ for the homozygous wild-type group, P=0.026). The inhibition of moclo-bemide metabolism was significant in extensive metabolizers even after a single dose of omeprazole. After daily administration of omeprazole for 1 week, the pharmacokinetic parameters of moclobemide and its metabolites in extensive metabolizers changed to values similar to those in poor metabolizers. In poor meta-bolizers, no remarkable changes in the pharmacokinetic parameters were observed. The area under the time-effect curves of visual analog scale(VAS), choice reaction time, and continuous line tracking test results of lorazepam was reduced by 20%, 7%, 23% respectively in induced state, and in spite of large interindividual variablity, significant statistical difference was shown in VAS(repeated measures ANOVA, p=0.0027).

  • PDF

이중에너지 X선 흡수법을 이용한 골밀도 측정시 99mTc-MDP 투여 전·후 측정값의 변화 (Change in the Measured Value at 99mTc-MDP Administration before and after Bone Density Measurement using the Dual Energy X-ray Absorptiometry)

  • 강용길;원도연;정홍문
    • 한국방사선학회논문지
    • /
    • 제11권1호
    • /
    • pp.43-48
    • /
    • 2017
  • 최근 동위원소를 이용한 뼈 스캔 (Bone Scan)검사 후 골밀도 (BMD; Bone Mineral Density)검사를 당일검사로 병행한 경우 이로 인한 골밀도 측정값에 오차 발생 가능성이 제기되고 있으나 방사성의약품 표지화합물 투여 후 이중에너지 X선을 이용한 골밀도 측정값 변화에 대한 임상적 자료가 미비하여 핵의학 체내검사 후 당일 골다공증 검사의 측정값에 대한 논란의 소지가 있다. 따라서 동위원소 표지화합물인 $^{99m}Tc-MDP$가 골밀도 측정값에 영향을 미치는지 임상적 측면에서 실험하였다. 실험에 참가한 대상자의 평균 나이는 $35.17{\pm}9.45$세로 실험 대상자 17명 중 대사성 질환과 골밀도 측정에 영향을 줄 수 있는 허리뼈 압박골절 및 몸쪽 넓적다리뼈 골절이 있는 자를 제외한 12명 중 정상 골밀도 T-scores>-1.0의 환자 6명을 대상으로 $^{99m}Tc-MDP$ 투여 전 후 측정값을 분석한 결과 허리뼈에서 전 후 각각 평균 $0.975{\pm}0.084g/cm^2$, $0.966{\pm}0.078g/cm^2$으로 $0.009g/cm^2$ 증가, 우측 몸쪽 넓적다리뼈에서는 전 후 각각 평균 $0.909{\pm}0.078g/cm^2$, $0.913{\pm}0.086g/cm^2$으로 $0.004g/cm^2$ 감소, 좌측 몸쪽 넓적다리뼈에서는 각각 평균 $0.887{\pm}0.099g/cm^2$, $0.881{\pm}0.103g/cm^2$으로 $0.007g/cm^2$의 증가를 보여 몸쪽 넓적다리뼈 보다 허리뼈에서 더 큰 골밀도 변화를 보여주었다. 그러나 허리뼈와 몸쪽 넓적다리뼈 전체에서 전 후 변화 평균은 $0.0038{\pm}0.014g/cm^2$으로 골밀도 측정값에 유의한 영향이 없음을 알 수 있으며, 또한 두 실험간 전체 상관계수는 0.987으로 방사성동위원소 표지화합물인 $^{99m}Tc-MDP$ 투여가 골밀도 측정값에 영향을 주지 않았다. 따라서 140 keV의 감마선 에너지를 방출하는 테크네슘 표지화합물을 이용한 뼈 스캔검사 후 골밀도 측정값에 유의한 영향을 미치지 않음을 확인하였다. 그러나 핵의학적 체내검사와 골다공증 검사를 당일로 검사함으로 인한 환자의 피폭을 고려한다면 시간 간격을 두고 검사를 시행하는 것이 좋을 것으로 사료된다.